| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE | 10 |
| 1 | METHOTREXATE SODIUM | 10 |
| 2 | FLUOROURACIL | 9 |
| 3 | FLUOROURACIL CREAM, 0.5% | 9 |
| 4 | OXALIPLATIN | 9 |
| 5 | INFLIXIMAB | 8 |
| 6 | PEGASPARGASE | 8 |
| 7 | ADALIMUMAB | 4 |
| 8 | LEVETIRACETAM | 4 |
| 9 | LEVETIRACETAM IN SODIUM CHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGASPARGASE | 8 | 0.0006 |
| 1 | VALPROATE SODIUM | 4 | 0.0002 |
| 2 | HUMAN IMMUNOGLOBULIN G | 3 | 0.0001 |
| 3 | ALECTINIB HYDROCHLORIDE | 1 | 0.0001 |
| 4 | OXALIPLATIN | 9 | 0.0001 |
| 5 | FLUOROURACIL CREAM, 0.5% | 9 | 0.0001 |
| 6 | FLUOROURACIL | 9 | 0.0001 |
| 7 | BRENTUXIMAB VEDOTIN | 1 | 0.0001 |
| 8 | TOPIRAMATE | 4 | 0.0001 |
| 9 | LEVETIRACETAM ORAL | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 8 | 0.0006 |
| 1 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 2 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 10 | 0.0000 |
| 4 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 10 | 0.0000 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 8 | Aromatic Amino Acid [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |